ESR1 and breast cancer: We have established a triple immunostaining protocol for the simultaneous investigation of estrogen receptor (ER), keratins (K) 8/18/19, and CD45 expression on our CTC model system (blood of healthy volunteers spiked with breast cancer cell line cells) with the possibility of further single cell ESR1 gene mutation analysis.